HDFC Pharma and Healthcare Fund - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.39 ↑ 0.35%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option 1.77% 0.35% 0.81% -1.48% -1.02% 6.87%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.01% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.99%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology10.47%
Divis Laboratories Ltd.Pharmaceuticals & Biotechnology7.76%
Glenmark Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology6.93%
Lupin Ltd.Pharmaceuticals & Biotechnology6.84%
Alkem Laboratories Ltd.Pharmaceuticals & Biotechnology5.94%
Max Healthcare Institute LimitedHealthcare Services4.66%
Ipca Laboratories Ltd.Pharmaceuticals & Biotechnology4.50%
Cipla Ltd.Pharmaceuticals & Biotechnology4.32%
Torrent Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology3.81%
Krishna Institute Of Medical Sciences LimitedHealthcare Services3.64%
Laurus Labs Ltd.Pharmaceuticals & Biotechnology3.58%
Aster DM Healthcare LimitedHealthcare Services3.55%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology3.26%
Eris Lifesciences LtdPharmaceuticals & Biotechnology3.19%
Metropolis Healthcare Ltd.Healthcare Services2.64%
Vijaya Diagnostic Centre LimitedHealthcare Services2.45%
Acutaas Chemicals LimitedPharmaceuticals & Biotechnology2.31%
Gland Pharma Ltd.Pharmaceuticals & Biotechnology2.12%
Wockhardt Ltd.Pharmaceuticals & Biotechnology2.07%
Cohance Lifesciences LimitedPharmaceuticals & Biotechnology1.99%
Dr. Lal Path Labs LtdHealthcare Services1.94%
Fortis Healthcare LimitedHealthcare Services1.89%
Jubilant Pharmova LimitedPharmaceuticals & Biotechnology1.81%
Piramal Pharma LimitedPharmaceuticals & Biotechnology1.79%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology1.67%
BAJAJ HEALTHCARE LIMITEDPharmaceuticals & Biotechnology1.34%
Pfizer Ltd.Pharmaceuticals & Biotechnology1.29%
Laxmi Dental LimitedHealthcare Equipment & Supplies1.11%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology0.14%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV history

DateNAV
20 October, 202517.39
17 October, 202517.33
16 October, 202517.269
15 October, 202517.181
14 October, 202517.135
13 October, 202517.25
10 October, 202517.245
9 October, 202517.076
8 October, 202516.999
7 October, 202517.075
6 October, 202517.033
3 October, 202516.907
1 October, 202516.945
30 September, 202516.761
29 September, 202516.768
26 September, 202516.745
25 September, 202517.134
24 September, 202517.267
23 September, 202517.348
22 September, 202517.401
19 September, 202517.651
18 September, 202517.493
17 September, 202517.371
16 September, 202517.435
15 September, 202517.374
12 September, 202517.443
11 September, 202517.404
10 September, 202517.369
9 September, 202517.332
8 September, 202517.236

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 17.39 as on 20 October, 2025.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 1.77% as on 20 October, 2025.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 6.87% as on 20 October, 2025.